This website uses functional cookies, including analytical cookies.
The obtained statistical data cannot be traced back to individual users.
Additionally, you can choose to accept or refuse consent to use marketing cookies.
If you decline these additional cookies or refrain from making a choice, only functional cookies will be set.
See our cookie policy for more information.
New Research Highlights Supply Chain Risk As Key To Addressing Drug Shortages
New Research Highlights Supply Chain Risk As Key To Addressing Drug Shortages
Article about the four-year research project by INSEAD and five other institutions (incl RSM) what reveals that understanding the interaction between medical criticality and supply chain risk is crucial for addressing drug shortages. Harwin de Vries and Stef Lemmens were co-authors.